🇺🇸 FDA
Pipeline program

AdV-tk

PaTK01

Phase 1 mab completed

Quick answer

AdV-tk for Pancreatic Adenocarcinoma is a Phase 1 program (mab) at Candel Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Candel Therapeutics
Indication
Pancreatic Adenocarcinoma
Phase
Phase 1
Modality
mab
Status
completed

Clinical trials